DD210306A5 - Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors zur expression von exogenem protein - Google Patents
Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors zur expression von exogenem protein Download PDFInfo
- Publication number
- DD210306A5 DD210306A5 DD25121483A DD25121483A DD210306A5 DD 210306 A5 DD210306 A5 DD 210306A5 DD 25121483 A DD25121483 A DD 25121483A DD 25121483 A DD25121483 A DD 25121483A DD 210306 A5 DD210306 A5 DD 210306A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- fragment
- sequence
- dna
- plasmid
- asp
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 87
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 69
- 239000013599 cloning vector Substances 0.000 title claims abstract description 18
- 108020004511 Recombinant DNA Proteins 0.000 title claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 108020004414 DNA Proteins 0.000 claims abstract description 98
- 238000000034 method Methods 0.000 claims abstract description 77
- 108090001030 Lipoproteins Proteins 0.000 claims abstract description 55
- 102000004895 Lipoproteins Human genes 0.000 claims abstract description 41
- 239000002773 nucleotide Substances 0.000 claims abstract description 38
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 37
- 108010013369 Enteropeptidase Proteins 0.000 claims abstract description 28
- 102100029727 Enteropeptidase Human genes 0.000 claims abstract description 27
- 238000003776 cleavage reaction Methods 0.000 claims abstract description 27
- 230000007017 scission Effects 0.000 claims abstract description 27
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims abstract description 21
- 108091081024 Start codon Proteins 0.000 claims abstract description 17
- 230000014621 translational initiation Effects 0.000 claims abstract description 8
- 230000010076 replication Effects 0.000 claims abstract description 5
- 239000012634 fragment Substances 0.000 claims description 162
- 239000013612 plasmid Substances 0.000 claims description 119
- 239000013598 vector Substances 0.000 claims description 48
- 241000588724 Escherichia coli Species 0.000 claims description 38
- 108010006025 bovine growth hormone Proteins 0.000 claims description 34
- 108010000521 Human Growth Hormone Proteins 0.000 claims description 31
- 102000002265 Human Growth Hormone Human genes 0.000 claims description 28
- 239000000854 Human Growth Hormone Substances 0.000 claims description 28
- 108091026890 Coding region Proteins 0.000 claims description 22
- 150000001413 amino acids Chemical class 0.000 claims description 22
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 13
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims description 12
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 102000053602 DNA Human genes 0.000 claims description 8
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 7
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 4
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 4
- 108091036066 Three prime untranslated region Proteins 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 230000005030 transcription termination Effects 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 108010060175 trypsinogen activation peptide Proteins 0.000 claims description 2
- 230000006820 DNA synthesis Effects 0.000 claims 2
- 108091023045 Untranslated Region Proteins 0.000 claims 2
- 241000272525 Anas platyrhynchos Species 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 54
- 239000000872 buffer Substances 0.000 description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 36
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 34
- 239000000499 gel Substances 0.000 description 28
- 229920002401 polyacrylamide Polymers 0.000 description 27
- 102000012410 DNA Ligases Human genes 0.000 description 24
- 108010061982 DNA Ligases Proteins 0.000 description 24
- 238000010367 cloning Methods 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 23
- 102000003960 Ligases Human genes 0.000 description 22
- 108090000364 Ligases Proteins 0.000 description 22
- 238000000605 extraction Methods 0.000 description 21
- 239000000047 product Substances 0.000 description 21
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 19
- 101150074251 lpp gene Proteins 0.000 description 18
- 239000011780 sodium chloride Substances 0.000 description 18
- 239000007983 Tris buffer Substances 0.000 description 16
- 108091008146 restriction endonucleases Proteins 0.000 description 16
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 16
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- 230000029087 digestion Effects 0.000 description 15
- 238000010276 construction Methods 0.000 description 14
- 238000001556 precipitation Methods 0.000 description 14
- 108020004705 Codon Proteins 0.000 description 13
- 229960000723 ampicillin Drugs 0.000 description 13
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 108020004999 messenger RNA Proteins 0.000 description 12
- 239000000463 material Substances 0.000 description 11
- 238000003127 radioimmunoassay Methods 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- 238000013519 translation Methods 0.000 description 11
- 239000011543 agarose gel Substances 0.000 description 10
- 238000001962 electrophoresis Methods 0.000 description 10
- 239000000543 intermediate Substances 0.000 description 10
- 239000004098 Tetracycline Substances 0.000 description 8
- 238000001502 gel electrophoresis Methods 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 229960002180 tetracycline Drugs 0.000 description 8
- 229930101283 tetracycline Natural products 0.000 description 8
- 235000019364 tetracycline Nutrition 0.000 description 8
- 150000003522 tetracyclines Chemical class 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- 239000013613 expression plasmid Substances 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 239000013600 plasmid vector Substances 0.000 description 7
- 108700031632 somatrem Proteins 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 6
- 241000607715 Serratia marcescens Species 0.000 description 6
- 230000000977 initiatory effect Effects 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 102000018997 Growth Hormone Human genes 0.000 description 4
- 108010051696 Growth Hormone Proteins 0.000 description 4
- 101710163270 Nuclease Proteins 0.000 description 4
- 241000607720 Serratia Species 0.000 description 4
- 108020005038 Terminator Codon Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 4
- 229960005542 ethidium bromide Drugs 0.000 description 4
- 239000000122 growth hormone Substances 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 4
- 241000588694 Erwinia amylovora Species 0.000 description 3
- 241000588722 Escherichia Species 0.000 description 3
- 241000588915 Klebsiella aerogenes Species 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 3
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 3
- 108700009124 Transcription Initiation Site Proteins 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000001817 pituitary effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000588919 Citrobacter freundii Species 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 2
- 241001131785 Escherichia coli HB101 Species 0.000 description 2
- 210000000712 G cell Anatomy 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 229940092559 enterobacter aerogenes Drugs 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 229940007046 shigella dysenteriae Drugs 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000936 Agarose Chemical group 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102400000748 Beta-endorphin Human genes 0.000 description 1
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 241000607471 Edwardsiella tarda Species 0.000 description 1
- 101900234631 Escherichia coli DNA polymerase I Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- GMGWMIJIGUYNAY-UHFFFAOYSA-N MeIQ Chemical compound CC1=CC2=NC=CC=C2C2=C1N(C)C(N)=N2 GMGWMIJIGUYNAY-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000364057 Peoria Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010076181 Proinsulin Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 1
- 108010076830 Thionins Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 229920004892 Triton X-102 Polymers 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 210000004349 growth plate Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000000110 microvilli Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000013014 purified material Substances 0.000 description 1
- 101150079601 recA gene Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000935 short-term exposure limit Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38199282A | 1982-05-25 | 1982-05-25 | |
| US38205182A | 1982-05-25 | 1982-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD210306A5 true DD210306A5 (de) | 1984-06-06 |
Family
ID=27009591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD25121483A DD210306A5 (de) | 1982-05-25 | 1983-05-24 | Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors zur expression von exogenem protein |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0095361B1 (hu) |
| JP (2) | JPH0759193B2 (hu) |
| AU (1) | AU560965B2 (hu) |
| CA (1) | CA1231068A (hu) |
| DD (1) | DD210306A5 (hu) |
| DE (1) | DE3380262D1 (hu) |
| DK (1) | DK230683A (hu) |
| GB (1) | GB2121054B (hu) |
| HU (1) | HU197349B (hu) |
| IE (1) | IE55244B1 (hu) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ201918A (en) * | 1981-09-18 | 1987-04-30 | Genentech Inc | N-terminal methionyl analogues of bovine growth hormone |
| EP0111814A3 (en) * | 1982-12-16 | 1985-08-14 | Mgi Pharma, Inc. | The cloning and expression of nucleotide sequences encoding bovine growth hormone |
| US4755465A (en) * | 1983-04-25 | 1988-07-05 | Genentech, Inc. | Secretion of correctly processed human growth hormone in E. coli and Pseudomonas |
| US4859600A (en) * | 1983-04-25 | 1989-08-22 | Genentech, Inc. | Recombinant procaryotic cell containing correctly processed human growth hormone |
| JP2551746B2 (ja) * | 1983-07-19 | 1996-11-06 | サントリー株式会社 | 改良プラスミドベクタ−およびその利用 |
| SU1491346A3 (ru) * | 1984-03-06 | 1989-06-30 | Эли Лилли Энд Компани (Фирма) | Способ получени рекомбинантной плазмидной ДНК, кодирующей синтез бычьего или человеческого гормона роста |
| EP0159123B1 (en) * | 1984-03-06 | 1992-01-15 | Eli Lilly And Company | Vectors for expressing bovine growth hormone derivatives |
| US4745179A (en) * | 1984-04-02 | 1988-05-17 | Fujisawa Pharmaceutical Co., Ltd. | 59 Valine insulin-like growth factor I and process for production thereof |
| GB8412517D0 (en) * | 1984-05-16 | 1984-06-20 | Nagai K | Recombinant fusion proteins |
| US5037806A (en) | 1985-02-22 | 1991-08-06 | Monsanto Company | Biologically active method using somatotropins |
| US4861868A (en) | 1985-02-22 | 1989-08-29 | Monsanto Company | Production of proteins in procaryotes |
| JPS61206908A (ja) * | 1985-03-08 | 1986-09-13 | Sony Corp | 磁気デイスク装置 |
| US4751180A (en) * | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US5342921A (en) * | 1985-03-28 | 1994-08-30 | Chiron Corporation | Superoxide dismutase fusion polypeptides for expression of mammalian proteins |
| US5173418A (en) * | 1985-05-10 | 1992-12-22 | Benzon Pharma, A/S | Production in Escherichia coli of extracellular Serratia spp. hydrolases |
| IL78703A (en) * | 1985-05-10 | 1993-02-21 | Benzon Alfred | Method of producing extracellular enzymes, the enzymes produced thereby and compositions containing them; a hybrid plasmid and a dna fragment comprising dna encoding the enzymes; a microorganism harbouring the plasmid; and a method for removing nucleic acids from biological materials |
| DE3731874A1 (de) * | 1987-09-18 | 1989-03-30 | Schering Ag | Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen |
| US5192669A (en) * | 1987-11-09 | 1993-03-09 | Eli Lilly And Company | Method to produce recombinant proteins using an expression vector comprising transcriptional and translational activating sequences |
| US5063158A (en) * | 1987-11-09 | 1991-11-05 | Eli Lilly And Company | Recombinant DNA expression vector comprising both transcriptional and translational activating sequences |
| IL90514A (en) * | 1988-06-03 | 1995-10-31 | Us Health | A fusion gene that contains a gene for multidrug resistance that is fused to a gene for adenine diamines |
| EP0763543A2 (en) | 1988-09-02 | 1997-03-19 | The Rockefeller University | A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
| EP0752853B1 (en) | 1993-03-10 | 2005-09-21 | Smithkline Beecham Corporation | Human brain phosphodiesterase |
| US5795776A (en) * | 1994-03-22 | 1998-08-18 | Bio-Technology General Corp. | Expression plasmids regulated by an OSMB promoter |
| AU7171098A (en) * | 1997-05-01 | 1998-11-24 | Board Of Regents, The University Of Texas System | Directed evolution of enzymes and antibodies |
| US6087128A (en) * | 1998-02-12 | 2000-07-11 | Ndsu Research Foundation | DNA encoding an avian E. coli iss |
| WO1999058662A1 (fr) * | 1998-05-14 | 1999-11-18 | Merck Patent Gmbh | Proteine fusionnee |
| DE102005014270A1 (de) * | 2005-03-24 | 2006-10-05 | Rhein Chemie Rheinau Gmbh | Verwendung von vernetzten Mikrogelen zur Modifikation des temperaturabhängigen Verhaltens von nicht-vernetzbaren organischen Medien |
| US11136613B2 (en) | 2015-04-30 | 2021-10-05 | Board Of Regents, The University Of Texas System | Antibacterial polypeptide libraries and methods for screening the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7811458L (sv) * | 1977-11-08 | 1979-05-09 | Genentech Inc | Forfarande och medel for polypeptidbildning via mikrober |
| ZA802992B (en) * | 1979-06-01 | 1981-10-28 | Univ California | Human pre-growth hormone |
| US4342832A (en) * | 1979-07-05 | 1982-08-03 | Genentech, Inc. | Method of constructing a replicable cloning vehicle having quasi-synthetic genes |
| CA1200773A (en) * | 1980-02-29 | 1986-02-18 | William J. Rutter | Expression linkers |
| IE52755B1 (en) * | 1980-08-26 | 1988-02-17 | Univ California | Bovine pre-growth and growth hormone |
| GR76959B (hu) * | 1981-01-02 | 1984-09-04 | Univ New York State Res Found | |
| NZ201918A (en) * | 1981-09-18 | 1987-04-30 | Genentech Inc | N-terminal methionyl analogues of bovine growth hormone |
-
1983
- 1983-05-23 EP EP83302935A patent/EP0095361B1/en not_active Expired
- 1983-05-23 IE IE121183A patent/IE55244B1/en not_active IP Right Cessation
- 1983-05-23 DE DE8383302935T patent/DE3380262D1/de not_active Expired
- 1983-05-23 HU HU181083A patent/HU197349B/hu not_active IP Right Cessation
- 1983-05-23 GB GB08314183A patent/GB2121054B/en not_active Expired
- 1983-05-24 JP JP58092197A patent/JPH0759193B2/ja not_active Expired - Lifetime
- 1983-05-24 DK DK230683A patent/DK230683A/da not_active Application Discontinuation
- 1983-05-24 DD DD25121483A patent/DD210306A5/de unknown
- 1983-05-24 CA CA000428700A patent/CA1231068A/en not_active Expired
- 1983-05-24 AU AU14912/83A patent/AU560965B2/en not_active Ceased
-
1992
- 1992-09-17 JP JP4351893A patent/JPH0673096A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU1491283A (en) | 1983-12-01 |
| EP0095361B1 (en) | 1989-07-26 |
| EP0095361A1 (en) | 1983-11-30 |
| CA1231068A (en) | 1988-01-05 |
| DK230683D0 (da) | 1983-05-24 |
| JPH0759193B2 (ja) | 1995-06-28 |
| AU560965B2 (en) | 1987-04-30 |
| HU197349B (en) | 1989-03-28 |
| IE55244B1 (en) | 1990-07-18 |
| JPS58219199A (ja) | 1983-12-20 |
| IE831211L (en) | 1983-11-25 |
| JPH0673096A (ja) | 1994-03-15 |
| DE3380262D1 (en) | 1989-08-31 |
| GB2121054B (en) | 1986-02-26 |
| GB2121054A (en) | 1983-12-14 |
| DK230683A (da) | 1983-11-26 |
| GB8314183D0 (en) | 1983-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD210306A5 (de) | Verfahren zur herstellung eines rekombinanten dna-klonierungsvektors zur expression von exogenem protein | |
| DE3050725C2 (hu) | ||
| DE3111405C2 (hu) | ||
| DE60208343T2 (de) | FUSIONSPROTEINE aus hirudin und proinsulin oder insulin | |
| US4745069A (en) | Cloning vectors for expression of exogenous protein | |
| DE2848053A1 (de) | Synthetische dna und verfahren zu ihrer herstellung | |
| DE2848052A1 (de) | Synthetische dna und verfahren zu ihrer herstellung | |
| DD212982A5 (de) | Verfahren zur herstellung von rinder-wachstumshormon-aehnlichen polypeptiden | |
| GB2116980A (en) | Human growth hormone variants | |
| EP1114865A1 (en) | Production of human parathyroid hormone | |
| WO1992003477A1 (en) | Biologically active compound, a process for the preparation thereof and use of the same | |
| DE69532646T2 (de) | Verfahren zur herstellung extrazellulärer proteine in bakterien | |
| DE69735242T2 (de) | N-terminal verlängerte proteine exprimiert in hefe | |
| EP0147178B1 (en) | Expression plasmids for improved production of heterologous protein in bacteria | |
| DD155004A5 (de) | Verfahren zur herstellung eines dns-transfervektors | |
| EP0301485B1 (de) | Expressionsvektoren und Verfahren unter deren Verwendung zur Gewinnung von Cro/beta-Galaktosidase/PTH-Fusionsproteinen und von PTH | |
| JP3319605B2 (ja) | ストレプトミセスにおける外来タン白質の製造法 | |
| DD298426A5 (de) | Verfahren zur herstellung von neuen plasmiden und deren verwendung bei der gewinnung eines plasminogenaktivators | |
| DE69634757T2 (de) | Vektor zur expression von n-terminal verlängerten proteinen in hefezellen | |
| DD210466A5 (de) | Verfahren zur herstellung eines rekombinanten plasmids | |
| US6194200B1 (en) | Expression systems for preparation of polypeptides in prokaryotic cells | |
| EP0393039B1 (en) | Process for producing peptides by specific cleavage of fusion proteins with collagenases obtained by genetic engineering | |
| DE3328793A1 (de) | Herstellung von sekretin | |
| WO1984000380A1 (en) | Vector | |
| DE3220333A1 (de) | 27-desamidosecretin und verfahren zu seiner herstellung durch rekombinierte dna-technologie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A5 | Published as prov. exclusive patent |